New diabetes clinical trial: SGLT2 INHIBITION for CARDIOVASCULAR ENDPOINT REDUCTION in HYPERTENSION

Published on: February 02, 2025 at 11:00PM
Conditions: Atrial Hypertension
Interventions: Drug: SGLT2; Drug: Placebo
Sponsors: Prof. Dr. med. Ingo Eitel
Not yet recruiting
https://ift.tt/okKrBYl